LakeShore Biopharma Co., Ltd: share_based_compensation
| Value | {"unit": "CNY", "value": 3505001, "concept": "us-gaap:ShareBasedCompensation"} |
|---|---|
| Period | 2022-04-01 – 2023-03-31 |
| Status | superseded |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9d0871a6-3e94-4ca9-b2ff-2e59c9db25c4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-23-060012Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/share-based-compensation/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9d0871a6-3e94-4ca9-b2ff-2e59c9db25c4
History
- no predecessors — first report